<DOC>
	<DOCNO>NCT00501839</DOCNO>
	<brief_summary>Anovulatory infertility common feature polycystic ovary syndrome ( PCOS ) . Clomiphene citrate ( CC ) represent first therapeutic option treat anovulatory infertility PCOS patient characterize low cost , limited dose-dependent side effect , simplicity administration management due need ongoing monitoring . Excellent result term ovulation obtain use CC . However , 50 % patient ovulate CC conceive . The exact explanation discrepancy ovulation pregnancy rate unknown , several hypothesis anti-estrogenic effect CC exert ovary uterus suggest . To date , data available optimal schedule CC administration , unknown long patient ovulate CC continue treatment switch second-line ovulation induction therapy . The aim study define clinical benefit CC administration accord duration administration .</brief_summary>
	<brief_title>Clomiphene Citrate Infertile PCOS Patients</brief_title>
	<detailed_description>Infertile PCOS patient three previous ovulatory cycle CC enrol randomize three group ( group A , B , C ) . In group A , patient receive cyclic progestogen nine month ; group B , patient continue CC treatment three cycle ovulate dos follow six month cyclic progestogen ; group C , patient continue CC administration ovulate dos nine cycle . In case , CC administer use traditional incremental-doses protocol 150 mg daily . All patient eligible undergo baseline assessment consist anthropometric , hormonal , ultrasonographic evaluation . During study , clinical reproductive outcome , adverse experience evaluate patient . Data analyze use intention-to-treat principle P value 0.05 less consider significant . Continuous variable analyze unpaired test general linear model repeat measure analysis Bonferroni test post-hoc analysis require . For categorical variable , Pearson chi-square Fisher 's exact test use . Cumulative pregnancy rate , primary end-point , calculate Kaplan-Maier method , difference two group assess log-rank test . Cox proportional-hazards model use calculate hazard ratio new pregnancy group .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Clomiphene</mesh_term>
	<mesh_term>Enclomiphene</mesh_term>
	<mesh_term>Zuclomiphene</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<criteria>Polycystic ovary syndrome ( use NIH criterion ) Anovulatory infertility ( use WHO criterion ) Previous three CCstimulated ovulatory cycle Age &lt; 18 &gt; 35 year Severe obesity ( BMI &gt; 35 ) Neoplastic , metabolic , hepatic , cardiovascular disorder concurrent medical illness Hypothyroidism , hyperprolactinemia , Cushing 's syndrome , nonclassical congenital adrenal hyperplasia Current previous ( within last six month ) use oral contraceptive , glucocorticoid , antiandrogens , antidiabetic antiobesity drug hormonal drug Intention start diet specific program physical activity Organic pelvic diseases Previous pelvic surgery Suspected peritoneal factor infertility Tubal male factor infertility subfertility</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Anovulation</keyword>
	<keyword>Clomiphene citrate</keyword>
	<keyword>Infertility</keyword>
	<keyword>PCOS</keyword>
	<keyword>Treatment</keyword>
</DOC>